MENA Newswire, NEW YORK: Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available in an oral pill form in the United States, marking a major…
Pfizer raised its 2025 profit forecast, driven by cost reductions and strong Q2 results, as Covid product sales and strategic initiatives boosted revenue.
Neurode Labs’ new brain-computer interface allows users to control devices with their thoughts, opening new possibilities in digital control, healthcare, and artificial intelligence.
The S&P 500 posted a 2.3% gain in August, reversing early losses, driven by strong performances in sectors like consumer staples, real estate, and healthcare.
